3M Company Corrects Ranger Blood/Fluid Warming System
The action addresses a discrepancy between the device's labeled and actual performance at high flow rates, which could pose a risk of patient hypothermia.
The action addresses a discrepancy between the device's labeled and actual performance at high flow rates, which could pose a risk of patient hypothermia.
The most serious type of recall was initiated due to a blocked manometer port, which can prevent pressure monitoring and lead to severe patient harm.
The Class I recall involves devices with incorrectly assembled B/V filters.
The action addresses a discrepancy between the device's labeled and actual performance at high flow rates, which could pose a risk of patient hypothermia.
Issues may cause therapy delays, false alarms, or thermal damage, though no injuries reported to date.
Read MoreWhile total recalls and units affected declined in Q1 2025, the number of Class I events increased.
Read MoreDevices are being removed from use after certain sizes were found to have smaller diameters than expected, potentially limiting airflow. Eight injuries have been reported.
Read MoreBD is correcting software for its Alaris Systems Manager and CCE Infusion Adapter after identifying a risk that outdated infusion parameters could be uploaded, potentially leading to incorrect dosing.
Read MoreThe FDA has issued an early alert regarding Baxter’s recall of certain Spectrum infusion pumps due to missing motor mounting screws, which may have occurred during servicing.
Read MoreSedgwick brand protection releases a year-in-review analysis of 2024 recall data, including the top five failures for medical devices.
Read MoreAbiomed has updated the use instructions for its Impella RP pumps due to a risk of device interaction that could damage the optical sensor or temporarily stop the pump.